The extraordinary story of scientists in East and West combatting HIV A small group of scientists were doggedly working in the field of antiviral treatments when the AIDS epidemic struck. Faced with one of the grand challenges of modern biology of the twentieth century, scientists worked across the political divide of the Cold War to produce a new class of antivirals. Their molecules were developed by a Californian start-up together with teams of scientists at the Rega Institute of KU Leuven and the Institute of Organic Chemistry and Biochemistry (IOCB) of the Academy of Sciences in Prague.…mehr
The extraordinary story of scientists in East and West combatting HIV A small group of scientists were doggedly working in the field of antiviral treatments when the AIDS epidemic struck. Faced with one of the grand challenges of modern biology of the twentieth century, scientists worked across the political divide of the Cold War to produce a new class of antivirals. Their molecules were developed by a Californian start-up together with teams of scientists at the Rega Institute of KU Leuven and the Institute of Organic Chemistry and Biochemistry (IOCB) of the Academy of Sciences in Prague. These molecules became the cornerstone of the blockbuster drugs now used to combat and prevent HIV. Cold War Triangle gives an insight into the human face of science as it recounts the extraordinary story of scientists in East and West who overcame ideological barriers and worked together for the benefit of humanity.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Foreword Acknowledgements Introduction A brief excursion into the history of virology and vaccines Chapter I. Leuven: a hotbed for antiviral research The cross-fertilization between academia and pharma Vaccines and celebrity scientists Chapter II. Behind the Iron Curtain The molecular revolution goes east The Academy of Sciences in Prague Chapter III. Strange bedfellows: a Czech chemist and a Flemish virologist Auspicious omens A young prodigy's path to science Chapter IV. The sixties in Leuven and Prague Antiviral penicillin Spring turns into winter Chapter V. Enzymes: the secret of life as chemistry At Stanford, a new world opens up The Rega Institute cuts corporate ties and goes its own way Chapter VI. From interferon to nucleosides A first encounter with nucleosides A fateful meeting in Göttingen Bringing compounds to life Chapter VII. Breaking away from interferon A molecule for all seasons Cloning the interferon gene Chapter VIII. The first antiviral drugs NA TO supports a nucleosides network Bringing antiviral therapy to the clinic Chapter IX. Aids emerges in the shadow of the Cold War The East German connection The Cold War heats up Revealing a retrovirus Chapter X. From passivity to action A pivotal year A triangular collaboration is set in motion Launching an aids laboratory in Leuven: the story of d4T Chapter XI. First attempts to halt the epidemic Two irons in the fire: Bristol-Myers and Janssen Taking stock after AZT Holý's compound is active against HIV Chapter XII. Finding the best therapy: the one-a-day-pill A new start-up: Gilead Sciences The birth of Cidofovir, Tenofovir and Adefovir Epilogue: Of scientists and crusaders Album Notes References Index
Foreword Acknowledgements Introduction A brief excursion into the history of virology and vaccines Chapter I. Leuven: a hotbed for antiviral research The cross-fertilization between academia and pharma Vaccines and celebrity scientists Chapter II. Behind the Iron Curtain The molecular revolution goes east The Academy of Sciences in Prague Chapter III. Strange bedfellows: a Czech chemist and a Flemish virologist Auspicious omens A young prodigy's path to science Chapter IV. The sixties in Leuven and Prague Antiviral penicillin Spring turns into winter Chapter V. Enzymes: the secret of life as chemistry At Stanford, a new world opens up The Rega Institute cuts corporate ties and goes its own way Chapter VI. From interferon to nucleosides A first encounter with nucleosides A fateful meeting in Göttingen Bringing compounds to life Chapter VII. Breaking away from interferon A molecule for all seasons Cloning the interferon gene Chapter VIII. The first antiviral drugs NA TO supports a nucleosides network Bringing antiviral therapy to the clinic Chapter IX. Aids emerges in the shadow of the Cold War The East German connection The Cold War heats up Revealing a retrovirus Chapter X. From passivity to action A pivotal year A triangular collaboration is set in motion Launching an aids laboratory in Leuven: the story of d4T Chapter XI. First attempts to halt the epidemic Two irons in the fire: Bristol-Myers and Janssen Taking stock after AZT Holý's compound is active against HIV Chapter XII. Finding the best therapy: the one-a-day-pill A new start-up: Gilead Sciences The birth of Cidofovir, Tenofovir and Adefovir Epilogue: Of scientists and crusaders Album Notes References Index
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826